AAAAAA
Results: 1-25/30
Authors:
Wahlers, A
Zipfel, PF
Schwieger, M
Ostertag, W
Baum, C
Citation: A. Wahlers et al., In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity, J VIROLOGY, 76(1), 2002, pp. 303-312
Authors:
Kraiczy, P
Skerka, C
Kirschfink, M
Zipfel, PF
Brade, V
Citation: P. Kraiczy et al., Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates, INT IMMUNO, 1(3), 2001, pp. 393-401
Authors:
Zipfel, PF
Skerka, C
Caprioli, J
Manuelian, T
Neumann, HH
Noris, M
Remuzzi, G
Citation: Pf. Zipfel et al., Complement factor H and hemolytic uremic syndrome, INT IMMUNO, 1(3), 2001, pp. 461-468
Authors:
Zipfel, PF
Citation: Pf. Zipfel, Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?, TRENDS IMMU, 22(7), 2001, pp. 345-348
Authors:
Russwurm, S
Stonans, I
Stonane, E
Wiederhold, M
Luber, A
Zipfel, PF
Deigner, HP
Reinhart, K
Citation: S. Russwurm et al., Procalcitonin and CGRP-I mRNA expression in various human tissues, SHOCK, 16(2), 2001, pp. 109-112
Authors:
Caprioli, J
Bettinaglio, P
Zipfel, PF
Amadei, B
Daina, E
Gamba, S
Skerka, C
Marziliano, N
Remuzzi, G
Noris, M
Citation: J. Caprioli et al., The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20, J AM S NEPH, 12(2), 2001, pp. 297-307
Authors:
Kotarsky, H
Gustafsson, M
Svensson, HG
Zipfel, PF
Truedsson, L
Sjobring, U
Citation: H. Kotarsky et al., Group A streptococcal phagocytosis resistance is independent of complementfactor H and factor H-like protein 1 binding, MOL MICROB, 41(4), 2001, pp. 817-826
Authors:
Jozsi, M
Kapus, A
Kerekes, K
Karman, J
Bajtay, Z
Zipfel, PF
Erdei, A
Citation: M. Jozsi et al., Characterization of factor H-related cell membrane molecules expressed by human B lymphocytes and neutrophil granulocytes, IMMUNOL LET, 77(1), 2001, pp. 55-62
Authors:
Zipfel, PF
Citation: Pf. Zipfel, Complement factor H: Physiology and pathophysiology, SEM THROMB, 27(3), 2001, pp. 191-199
Authors:
Pio, R
Martinez, A
Unsworth, EJ
Kowalak, JA
Bengoechea, JA
Zipfel, PF
Elsasser, TH
Cuttitta, F
Citation: R. Pio et al., Complement factor H is a serum-binding protein for adrenomedullin, and theresulting complex modulates the bioactivities of both partners, J BIOL CHEM, 276(15), 2001, pp. 12292-12300
Authors:
Kraiczy, P
Skerka, C
Brade, V
Zipfel, PF
Citation: P. Kraiczy et al., Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi, INFEC IMMUN, 69(12), 2001, pp. 7800-7809
Authors:
Kraiczy, P
Skerka, C
Kirschfink, M
Brade, V
Zipfel, PF
Citation: P. Kraiczy et al., Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H, EUR J IMMUN, 31(6), 2001, pp. 1674-1684
Authors:
Kemper, C
Gigli, I
Zipfel, PF
Citation: C. Kemper et al., Conservation of plasma regulatory proteins of the complement system in evolution: Humans and fish, EXP CLIN IM, 17(2), 2000, pp. 55-62
Authors:
Skerka, C
Abel, WO
Zipfel, PF
Citation: C. Skerka et al., Two human gene families display preferences for different nucleotides and have distinct codon usage patterns, EXP CLIN IM, 17(1), 2000, pp. 29-41
Authors:
Junnikkala, S
Jokiranta, TS
Friese, MA
Jarva, H
Zipfel, PF
Meri, S
Citation: S. Junnikkala et al., Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1, J IMMUNOL, 164(11), 2000, pp. 6075-6081
Authors:
Jokiranta, TS
Hellwage, J
Koistinen, V
Zipfel, PF
Meri, S
Citation: Ts. Jokiranta et al., Each of the three binding sites on complement factor H interacts with a distinct site on C3b, J BIOL CHEM, 275(36), 2000, pp. 27657-27662
Authors:
Friese, MA
Hellwage, J
Jokiranta, TS
Meri, S
Muller-Quernheim, HJ
Peter, HH
Eibel, H
Zipfel, PF
Citation: Ma. Friese et al., Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA), CLIN EXP IM, 121(2), 2000, pp. 406-415
Authors:
Russwurm, S
Wiederhold, M
Oberhoffer, M
Stonans, I
Zipfel, PF
Reinhart, K
Citation: S. Russwurm et al., Molecular aspects and natural source of procalcitonin, CLIN CH L M, 37(8), 1999, pp. 789-797
Authors:
Russwurm, S
Oberhoffer, M
Zipfel, PF
Reinhart, K
Citation: S. Russwurm et al., Procalcitonin - a novel biochemical marker for the mediator-directed therapy of sepsis, MOL MED TOD, 5(7), 1999, pp. 286-287
Authors:
Somoskovi, A
Zissel, G
Zipfel, PF
Ziegenhagen, MW
Klaucke, J
Haas, H
Schlaak, M
Muller-Quernheim, J
Citation: A. Somoskovi et al., Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis, EUR CYTOKIN, 10(2), 1999, pp. 135-141
Authors:
Berendji, D
Kolb-Bachofen, V
Zipfel, PF
Skerka, C
Carlberg, C
Kroncke, KD
Citation: D. Berendji et al., Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression: Inhibition of IL-2 gene expression in murine lymphocytes, MOL MED, 5(11), 1999, pp. 721-730
Authors:
Noris, M
Ruggenenti, P
Perna, A
Orisio, S
Caprioli, J
Skerka, C
Vasile, B
Zipfel, PF
Remuzzi, G
Citation: M. Noris et al., Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Role of factor H abnormalities, J AM S NEPH, 10(2), 1999, pp. 281-293
Authors:
Zipfel, PF
Skerka, C
Citation: Pf. Zipfel et C. Skerka, FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function, IMMUNOL TOD, 20(3), 1999, pp. 135-140
Authors:
Zipfel, PF
Jokiranta, TS
Hellwage, J
Koistinen, V
Meri, S
Citation: Pf. Zipfel et al., The factor H protein family, IMMUNOPHARM, 42(1-3), 1999, pp. 53-60
Authors:
Zipfel, PF
Hellwage, J
Friese, MA
Hegasy, G
Jokiranta, ST
Meri, S
Citation: Pf. Zipfel et al., Factor H and disease: a complement regulator affects vital body functions, MOL IMMUNOL, 36(4-5), 1999, pp. 241-248